$GBTG

Al-Thani Faisal Saoud F.Q. sold (to issuer) 54,245 shares of GBTG

Al-Thani Faisal Saoud F.Q. sold (to issuer) 54,245 shares of Global Business Travel Group, Inc. (GBTG) across 2 trades on 2026-09-29.

Original reporting
SEC EDGAR · Al-Thani Faisal Saoud F.Q.
Published Sep 29, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GBTG
Bearish
medium confidence
Mentioned
$GBTG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GBTGBearishLow
01

Why it matters

The director’s exit may be interpreted as a negative signal, but the lack of price information limits the material impact.

02

Market read

Primary insider sale; modest relevance for short‑term traders monitoring GBTG.

03

What to watch

No price disclosed; the sale may have been executed at a favorable price or part of a pre‑arranged plan not reflected in the filing.

Relevance 4/10Novelty 3/10Timing: after market close today

Background

SEC Form 4 filings provide the first public disclosure of insider transactions. This filing reports a director’s complete exit from Global Business Travel Group.

Company-level read

Ticker impact

$GBTGBearishMedium confidence
Context

Director Al‑Thani Faisal Saoud F.Q. sold 54,245 shares of Global Business Travel Group in a Form 4 filing, reducing his stake to zero.

Expected impact

potential slight downward pressure as the market prices the insider sell

Evidence & confidence

Director-level insider sold a sizable block without disclosed price; no buy‑back or other mitigating information, so traders may view it as a modest bearish cue.

Market effects

Minimal; the travel services sector is not broadly affected by a single director's sale.

None; the filing is company‑specific.

Low; only relevant to investors in GBTG.

Counterpoint

The sale could be a routine liquidity event unrelated to fundamentals, so the stock may remain unchanged.

Key entities

  • Global Business Travel Group, Inc.

    US‑listed travel services provider (NASDAQ: GBTG).

  • Al‑Thani Faisal Saoud F.Q.

    Director of GBTG who sold his entire shareholding.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HRLMedAI 8/10

Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankrupt

Hormel (HRL) acquires Brakebush for $1.06B; Onsemi (ON) to buy Synaptics for $5.7B; Leslie's files for bankruptcy. Valley National (VLY) to acquire Bluevine for $340M. Yext (YEXT) to acquire Flamel.ai. Lifecore (LFCR) to be acquired by Webster Equity for up to $663.7M. SoftBank completes DigitalBridge acquisition. GBTG acquired by Long Lake for $6.3B.

$INTUMed

Q2 Earnings Highs And Lows: Intuit (NASDAQ:INTU) Vs The Rest Of The Finance and HR Software Stocks

Intuit (INTU) reported Q2 revenue of $4.35B, up 13.7% YoY, but missed EPS guidance, causing shares to drop 12.5%. American Express Global Business Travel (GBTG) saw 37.9% revenue growth, beating estimates. Marqeta (MQ) reported $176M revenue, up 17% YoY, but missed guidance. Paylocity (PCTY) beat estimates with 11% growth. BlackLine (BL) reported $187.8M revenue, in line with expectations but down 13.2% post-earnings.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).